Skip to main content

Advertisement

SpringerLink
Log in

Essential tremor

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Multiple pharmacologic treatments have been studied, but propranolol and primidone have proven to be the most effective medications. It is unlikely that a patient will respond miraculously to another medication if his or her response to propranolol and primidone is minimal. Some subsets of essential tremor, however, such as the kinetic predominant type may respond better to other medications. Mildly affected patients may not need treatment at all, and the potential benefits must always be weighed against the possible side effects The main benefit of botulinum toxin injection is for head tremor, whereas its efficacy in hand tremor is variable. If a patient does not respond to adequate doses of propranolol or primidone, deep brain stimulation should be considered because it carries the lowest risk of the available surgical procedures; usually, it should be given preference over thalamotomy. It is important for the physician to realize the multitude of symptomatic treatments available. Beyond the conventional and often effective oral medications, use of newer treatments such as botulinum toxin, thalamotomy, and deep brain stimulation can often reduce tremor and lead to a greater quality of life for patients with ET.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Koller WC, Busenbark K, Hubble JP: Essential tremor. In Neurodegenerative disease. Edited by Calne DB. Philadelphia: WB Saunders; 1994:717–742.

    Google Scholar 

  2. Parkinson J: An Essay on the Shaking Palsy. London: Whittingham & Rowland; 1817.

    Google Scholar 

  3. Dana CL: Hereditary tremor, a hitherto undescribed form of motor neurosis. Am J Med Sci 1887, 94:386–393.

    Article  Google Scholar 

  4. Critchley M: Observation on essential (heredofamilial) tremor. Brain 1949, 72:113–139.

    Article  PubMed  CAS  Google Scholar 

  5. Jankovic J, Beach J, Schwartz K, et al.: Tremor and longevity in relatives of patients with Parkinson’s disease, essential tremor and control subjects. Neurology 1995, 45:645–648.

    PubMed  CAS  Google Scholar 

  6. Katzenstein E: Uber familiaren tremor. Arch Suisses Neurol Psychiatry 1948, 61:380–381.

    CAS  Google Scholar 

  7. Busenbark KL, Nash J, Nash S, et al.: Is essential tremor benign? Neurology 1991, 41:1982–1983.

    PubMed  CAS  Google Scholar 

  8. Growdon JH, Shanani BT, Young RR: The effect of alcohol on essential tremor. Neurolog 1975, 25:259–262.

    CAS  Google Scholar 

  9. Lakie M, Walsh EG, Arblaster LA, et al.: Limb temperature and human tremors. J Neurol Neurosurg Psychiatry 1994, 57:35–42.

    PubMed  CAS  Google Scholar 

  10. Van Hilten JJ, van Dijk JG, Dunnewold RJW, et al.: Diurnal variation of essential and physiological tremor. J Neurol Neurosurg Psychiatr 1991, 54:516–519.

    PubMed  Google Scholar 

  11. Larson T, Sjögren T: Essential tremor: a clinical and genetic population study. Acta Psych Neurol Scand 1960, 36(suppl 144):1–176.

    Google Scholar 

  12. Busenbark K, Barnes P, Lyons K, et al.: Accuracy of reported family histories of essential tremor. Neurolog 1996, 47:264–265.

    CAS  Google Scholar 

  13. Biary N, Koller W: Kinetic predominant essential tremor: successful treatment with clonazepam. Neurolog 1987, 37:471–474.

    CAS  Google Scholar 

  14. Sheehy MP, Marsden CD: Writer’s cramp-a focal dystonia. Brain 1982, 105:461–480.

    Article  PubMed  Google Scholar 

  15. Gabellini AS, Martinelli P, Gulli ME, et al.: Orthostatic tremor: essential and symptomatic cases. Acta Neurol Scand 1990, 81:111–112.

    Google Scholar 

  16. Colebatch JG, Findley LJ, Frachowiak RSJ, et al.: Preliminary report: activation of the cerebellum in essential tremor. Lancet 1990, 336:1028–1030.

    Article  PubMed  CAS  Google Scholar 

  17. Kuroda Y, Kakigi R, Shibasaki H: Treatment of essential tremor with arotinolol. Neurolog 1988, 38:650–652.

    CAS  Google Scholar 

  18. Chung W, Poppen R, Lundervold DA: Behavioral relaxation training for tremor disorders in older adults. Biofeedback Self Regul 1995, 20:123–135.

    Article  PubMed  CAS  Google Scholar 

  19. Jankovic J: Tremors: diagnosis and treatment. In Eighth Annual Review Course: A Comprehensive Review of Movement Disorders for the Clinical Practitioner Fahn S, Marsden CD, Jankovic J. New York: Columbia University; 1998:749–779. An excellent and extremely thorough review of the topic.

    Google Scholar 

  20. Koller WC: Dose-response relationship of propranolol in essential tremor. Arch Neurol 1986, 35:42–43.

    Google Scholar 

  21. Koller WC: Long-acting propranolol in essential tremor. Neurology 1985, 35:108–110.

    PubMed  CAS  Google Scholar 

  22. Koller WC, Graner D, Mlcoch A: Essential voice tremor: treatment with propranolol. Neurolog 1985, 35:106–108.

    CAS  Google Scholar 

  23. Koller WC, Biary N: Metoprolol compared with propranolol in the treatment of essential tremor. Arch Neurol 1984, 41:171–172.

    PubMed  CAS  Google Scholar 

  24. Koller WC: Nadolol in the treatment of essential tremor. Neurology 1983, 33:1074–1075.

    PubMed  CAS  Google Scholar 

  25. Jefferson D, Jenner P, Marsden CD: Beta-adrenoreceptor antagonists in essential tremor Lancet 1984, 1(8381):856–857.

    Google Scholar 

  26. Dietrichson P, Espen E: Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recordings. J Neurol Neurosurg Psychiatr 1981, 44:677–683.

    PubMed  CAS  Google Scholar 

  27. Rowland LP: Current Neurologic Drugs. Philadelphia: Williams & Wilkins; 1998.

    Google Scholar 

  28. O’Brian MD, Upton AR, Toseland PA: Benign familial tremor treated with primidone. Br Med J 1981, 282:178–180.

    Article  Google Scholar 

  29. Koller WC, Royse V: Efficacy of primidone in essential tremor. Neurology 1986, 36:121–124.

    PubMed  CAS  Google Scholar 

  30. Lou JS, Jankovic J: Essential tremor: clinical correlates in 350 patients. Neurology 1991, 41:234–238.

    PubMed  CAS  Google Scholar 

  31. Koller WC: Alcoholism in essential tremor. Neurolog 1983, 33:1074–1076.

    CAS  Google Scholar 

  32. Thompson C, Lang A, Parkes JD, Marsden CD: A doubleblind trial of clonazepam in benign essential tremor. Clin Neuropharmacol 1984, 7:83–88.

    Article  PubMed  CAS  Google Scholar 

  33. Pape SM, Gershanik OS: Orthostatic tremor: an essential tremor variant. Movement Disor 1988, 3:97–108.

    Article  Google Scholar 

  34. Huber SJ, Paulson GW: Efficacy of alprazolam for essential tremor. Neurology 1988, 38:241–243.

    PubMed  CAS  Google Scholar 

  35. Biary N, Bahou Y, Sofi MA: The effect of nimodipine on essential tremor. Neurolog 1995, 45:1523–1525.

    CAS  Google Scholar 

  36. Biary N, Al Deeb SM, Langenberg P: The effect of flunarizine on essential tremor. Neurolog 1991, 41:311–312.

    CAS  Google Scholar 

  37. Busenbark K, Ramig L, Dromey C, et al.: Methazolamide for essential voice tremor. Neurology 1996, 47:1331–1332.

    PubMed  CAS  Google Scholar 

  38. Busenbark K, Pahwa R, Hubble J, et al.: Double-blind controlled study of methazolamide in the treatment of essential tremor. Neurology 1993, 43:1045–1047.

    PubMed  CAS  Google Scholar 

  39. Busenbark K, Hubble J, Pahwa P, et al.: The effect of acetazolamide on essential tremor. Neurology 1992, 42:1394–1395.

    PubMed  CAS  Google Scholar 

  40. Pahwa R, Lyons K, Hubble JP, et al.: Double-blind controlled trial of gabapentin in essential tremor. Movement Disord 1998, 13:465–467.

    Article  PubMed  CAS  Google Scholar 

  41. Ceravolo R, Salvetti S, Dell’Agnello G, et al.: Pharmacologic tools in the study of essential tremor Movement Disor 1996, 11(suppl 1):255.

    Google Scholar 

  42. Mally J, Stone TW: Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. J Neurol Sci 1995, 2:129–132.

    Article  Google Scholar 

  43. Wissel J, Masuhr F, Schelosky L, et al.: Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Movement Disor 1997, 12:722–726.

    Article  CAS  Google Scholar 

  44. Trosch RM, Pullman SL: Botulinum toxin A injections for the treatment of hand tremors. Movement Disor 1994, 9:601–609.

    Article  CAS  Google Scholar 

  45. Jankovic J, Schwartz K, Clemence W, et al.: A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Movement Disord 1996, 11:250–256.

    Article  PubMed  CAS  Google Scholar 

  46. Ludlow CL, Sedory SE, Fujita M, et al.: Treatment of voice tremor with botulinum toxin injection [abstract]. Neurolog 1989, 39(suppl 1):353.

    Google Scholar 

  47. Jankovic J, Schwartz K: Botulinum toxin treatment of tremors. Neurology 1991, 41:1185–1188.

    PubMed  CAS  Google Scholar 

  48. Brin MF, Tsui JKC: Applications of botulinum toxin: cranial dystonia. In Handbook of Dystonia. Edited by Tsui JKC, Calne DB. New York: Marcel Dekker; 1995:391–413.

    Google Scholar 

  49. Koller WC, Busenbark KL: Essential tremor. In Movement Disorders: Neurologic Principles and Practice. Edited by Watts RL, Koller WC. New York: McGraw-Hill; 1997:365–385.

    Google Scholar 

  50. Mohadjer M, Goerke H, Milios E, et al.: Long-term results of stereotaxy in the treatment of essential tremor. Stereotact Funct Neurosurg 1990, 54-55:125–129.

    Article  PubMed  CAS  Google Scholar 

  51. Alesh F, Pinter MM, Helscher RJ, et al.: Stimulation of the ventral intermediate thalamic nucleus in tremor dominated parkinson’s disease and essential tremor. Acta Neurochir (Wien) 1995, 136:75–81.

    Article  Google Scholar 

  52. Hubble JP, Busenbark KL, Wilkinson S, et al.: Deep brain stimulation for essential tremor. Neurology 1996, 46:1150–1153. A recent study of the efficacy and safety of deep brain stimulation in 10 patients with ET

    PubMed  CAS  Google Scholar 

  53. Carpenter MA, Pahwa R, Miyawai KL, et al.: Reduction in voice tremor under thalamic stimulation. Neurology 1998, 50:796–798. An interesting study of seven patients that noted improvement in voice tremor after they underwent deep brain stimulation for the management of hand tremor.

    PubMed  CAS  Google Scholar 

  54. Hubble JP, Busenbark KL, Wilkinson S, et al.: Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Movement Disor 1997, 12:337–341. An important study showing that deep brain stimulation produces improvement in disability brought on by tremor regardless of etiology. Scores for essential tremor and Parkinson’s disease were essentially equal.

    Article  CAS  Google Scholar 

  55. Hariz G-M, Bergenheim AT, Hariz MI, et al.: Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor. Movement Disor 1998, 13:78–83.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Southern California, 1510 San Pablo Street, HCC Suite 615, 90033, Los Angeles, CA, USA

    Dorothee Lambert MD & Cheryl H. Waters MD

Authors
  1. Dorothee Lambert MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheryl H. Waters MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lambert, D., Waters, C.H. Essential tremor. Curr Treat Options Neurol 1, 6–13 (1999). https://doi.org/10.1007/s11940-999-0027-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-999-0027-3

Keywords

Search

Navigation